Red Cedar Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$18K Hold
229
0.01% 116
2022
Q3
$18K Hold
229
0.01% 114
2022
Q2
$21K Hold
229
0.01% 111
2022
Q1
$25K Hold
229
0.02% 109
2021
Q4
$24K Hold
229
0.01% 107
2021
Q3
$29K Hold
229
0.02% 96
2021
Q2
$28K Hold
229
0.02% 100
2021
Q1
$27K Hold
229
0.02% 102
2020
Q4
$27K Hold
229
0.02% 99
2020
Q3
$24K Hold
229
0.02% 98
2020
Q2
$21K Hold
229
0.02% 100
2020
Q1
$21K Hold
229
0.02% 97
2019
Q4
$26K Hold
229
0.02% 102
2019
Q3
$25K Hold
229
0.02% 102
2019
Q2
$22K Hold
229
0.02% 109
2019
Q1
$21K Hold
229
0.02% 109
2018
Q4
$21K Hold
229
0.02% 106
2018
Q3
$23K Hold
229
0.02% 107
2018
Q2
$20K Hold
229
0.02% 110
2018
Q1
$18K Hold
229
0.02% 113
2017
Q4
$18K Buy
+229
New +$18.3K 0.02% 112

Other funds holding MDT

Red Cedar Capital's MDT Position: Q4 2022 in Review

Red Cedar Capital held its Medtronic (MDT) position steady in Q4 2022 at 229 shares worth $18K. The position accounts for 0.01% of the portfolio, ranked #116.

Red Cedar Capital first reported a position in MDT in Q4 2017 and has held it in 21 quarters since. The position peaked at $29K in Q3 2021. 1,961 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • Red Cedar Capital held 229 shares of Medtronic worth $18K as of Q4 2022.
  • Red Cedar Capital left its Medtronic share count unchanged in Q4 2022.
  • Medtronic made up 0.01% of Red Cedar Capital's portfolio in Q4 2022, its #116 holding.
  • Red Cedar Capital first reported a position in Medtronic in Q4 2017 and has held it in 21 quarters since.
  • Red Cedar Capital's Medtronic position peaked at $29K in Q3 2021.
  • 1,961 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Red Cedar Capital's 13F filing for Q4 2022, filed 6 Feb 2023.